Zylox-Tonbridge (02190.HK) Reports Increased H Share Capital and Treasury Shares in November 2025

Bulletin Express12-02

Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK) disclosed that the authorized share capital of its H shares rose from 322,400,744 to 336,350,744, while domestic shares remained at 7,781,257. This resulted in a total authorized share capital of 344,132,001. The number of H shares in issue, excluding treasury shares, grew from 315,804,613 to 329,504,613 during November 2025, and treasury shares increased from 6,596,131 to 6,846,131.

The change largely stemmed from the 2025 Share Incentive Scheme, which granted 13,950,000 Restricted Share Units during the month. Additionally, 250,000 H shares were repurchased and classified as treasury shares, reflecting the net increase in treasury holdings. The data provided indicates that the total improvement in issued H shares (excluding treasury shares) amounted to 13,700,000 over the reporting period, with the new total reaching 336,350,744 H shares by the end of November 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1100664278?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 17:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100664278","market":"hk","top_or_hot":-1,"title":"Zylox-Tonbridge (02190.HK) Reports Increased H Share Capital and Treasury Shares in November 2025","media":"Bulletin Express","content":"<p>Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK) disclosed that the authorized share capital of its H shares rose from 322,400,744 to 336,350,744, while domestic shares remained at 7,781,257. This resulted in a total authorized share capital of 344,132,001. The number of H shares in issue, excluding treasury shares, grew from 315,804,613 to 329,504,613 during November 2025, and treasury shares increased from 6,596,131 to 6,846,131.</p>\n<p>The change largely stemmed from the 2025 Share Incentive Scheme, which granted 13,950,000 Restricted Share Units during the month. Additionally, 250,000 H shares were repurchased and classified as treasury shares, reflecting the net increase in treasury holdings. The data provided indicates that the total improvement in issued H shares (excluding treasury shares) amounted to 13,700,000 over the reporting period, with the new total reaching 336,350,744 H shares by the end of November 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zylox-Tonbridge (02190.HK) Reports Increased H Share Capital and Treasury Shares in November 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZylox-Tonbridge (02190.HK) Reports Increased H Share Capital and Treasury Shares in November 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-12-02 17:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK) disclosed that the authorized share capital of its H shares rose from 322,400,744 to 336,350,744, while domestic shares remained at 7,781,257. This resulted in a total authorized share capital of 344,132,001. The number of H shares in issue, excluding treasury shares, grew from 315,804,613 to 329,504,613 during November 2025, and treasury shares increased from 6,596,131 to 6,846,131.</p>\n<p>The change largely stemmed from the 2025 Share Incentive Scheme, which granted 13,950,000 Restricted Share Units during the month. Additionally, 250,000 H shares were repurchased and classified as treasury shares, reflecting the net increase in treasury holdings. The data provided indicates that the total improvement in issued H shares (excluding treasury shares) amounted to 13,700,000 over the reporting period, with the new total reaching 336,350,744 H shares by the end of November 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1100664278","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100664278","pubTimestamp":1764668829,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK) disclosed that the authorized share capital of its H shares rose from 322,400,744 to 336,350,744, while domestic shares remained at 7,781,257....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"归乐通桥(02190.HK)公布于2025年11月增加H股本及库存股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Zylox-Tonbridge Medical Technology Co., Ltd. (02190.HK) disclosed that the authorized share capital of its H shares rose from 322,400,744 to 336,350,744, while domestic shares remained at 7,781,257. This resulted in a total authorized share capital of 344,132,001. The number of H shares in issue, excluding treasury shares, grew from 315,804,613 to 329,504,613 during November 2025, and treasury shares increased from 6,596,131 to 6,846,131.\nThe change largely stemmed from the 2025 Share Incentive Scheme, which granted 13,950,000 Restricted Share Units during the month. Additionally, 250,000 H shares were repurchased and classified as treasury shares, reflecting the net increase in treasury holdings. The data provided indicates that the total improvement in issued H shares (excluding treasury shares) amounted to 13,700,000 over the reporting period, with the new total reaching 336,350,744 H shares by the end of November 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1100664278","isCrawlerRequest":true}